Detalhe da pesquisa
1.
The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment.
CA Cancer J Clin
; 68(2): 153-165, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29338071
2.
Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores.
Breast Cancer Res Treat
; 203(1): 153-161, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768520
3.
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial.
Eur Heart J
; 44(46): 4878-4889, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806405
4.
Risk factors for financial toxicity in patients with gynecologic cancer.
Am J Obstet Gynecol
; 226(6): 817.e1-817.e9, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902319
5.
Oral Chemotherapy Metric Performance in Quality Oncology Practice Initiative Practices: Updated Trends and Analysis.
J Natl Compr Canc Netw
; 20(10): 1099-1106.e2, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240846
6.
Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.
JAMA
; 327(24): 2413-2422, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35661856
7.
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer.
Breast Cancer Res Treat
; 183(1): 227-237, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32613539
8.
A pilot randomized controlled trial of cognitive bias modification to reduce fear of breast cancer recurrence.
Cancer
; 123(8): 1424-1433, 2017 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28055119
9.
Cost-Effectiveness of Adjuvant Olaparib for Patients With Breast Cancer and Germline BRCA1/2 Mutations.
JAMA Netw Open
; 7(1): e2350067, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38170520
10.
Implementing a breast cancer registry and treatment plan/summary program in clinical practice: a pilot program.
Cancer
; 119(1): 158-63, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23197186
11.
Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program.
Cancer
; 119(1): 164-72, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23197335
12.
The microbial flora of taxane therapy-associated nail disease in cancer patients.
J Am Acad Dermatol
; 78(3): 607-609, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29447679
13.
Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39).
J Clin Oncol
; 41(29): 4652-4663, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625107
14.
Return to work in low-income Latina and non-Latina white breast cancer survivors: a 3-year longitudinal study.
Cancer
; 118(6): 1664-74, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22009703
15.
Cancer-Related Care Costs and Employment Disruption: Recommendations to Reduce Patient Economic Burden as Part of Cancer Care Delivery.
J Natl Cancer Inst Monogr
; 2022(59): 79-84, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788373
16.
An interactive mobile application versus an educational booklet to promote job retention in women undergoing adjuvant chemotherapy for breast cancer: a randomized controlled trial.
Trials
; 23(1): 840, 2022 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192754
17.
Breast Cancer-Related Employment Disruption and Financial Hardship in the Sister Study.
JNCI Cancer Spectr
; 5(3)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34104865
18.
Use of patient-reported controls for secular trends to study disparities in cancer-related job loss.
J Cancer Surviv
; 15(5): 685-695, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106995
19.
Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0.
J Clin Oncol
; 39(24): 2720-2731, 2021 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34003702
20.
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study.
Clin Cancer Res
; 26(21): 5609-5620, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32847933